FDA Inspection 592267 — Spear Dermatology Products Inc.

Spear Dermatology Products Inc. — FEI 3005597330

The FDA completed an inspection of Spear Dermatology Products Inc. on Jun 18, 2009 in Randolph, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 18, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Randolph, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
438921 CFR 211.198(a)Procedures to be written and followed
684221 CFR 314.80(j)Failure to maintain records

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.